The structure and function of glutamate receptors: Mg2+ block to X-ray diffraction

Experiments on the action of glutamate on mammalian and amphibian nervous systems started back in the 1950s but decades passed before it became widely accepted that glutamate was the major excitatory neurotransmitter in the CNS. The pace of research greatly accelerated in the 1980s when selective li...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Neuropharmacology Ročník 112; číslo Pt A; s. 4 - 10
Hlavní autor: Mayer, Mark L.
Médium: Journal Article
Jazyk:angličtina
Vydáno: Elsevier Ltd 01.01.2017
Témata:
Glutamate receptors
Structural biology
Glutamate receptors
Structural biology
ISSN:0028-3908, 1873-7064
On-line přístup:Získat plný text
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Popis
Shrnutí:Experiments on the action of glutamate on mammalian and amphibian nervous systems started back in the 1950s but decades passed before it became widely accepted that glutamate was the major excitatory neurotransmitter in the CNS. The pace of research greatly accelerated in the 1980s when selective ligands that identified glutamate receptor subtypes became widely available, and voltage clamp techniques, coupled with rapid perfusion, began to resolve the unique functional properties of what cloning subsequently revealed to be a large family of receptors with numerous subtypes. More recently the power of X-ray crystallography and cryo-EM has been applied to the study of glutamate receptors, revealing their atomic structures, and the conformational changes that underlie their gating. In this review I summarize the history of this field, viewed through the lens of a career in which I spent 3 decades working on the structure and function of glutamate receptor ion channels. This article is part of the Special Issue entitled ‘Ionotropic glutamate receptors’.
Bibliografie:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
ISSN:0028-3908
1873-7064
DOI:10.1016/j.neuropharm.2016.04.039